Genetic Technologies Ltd.
GENE
GENE was delisted on the 16th of October, 2024.
14 hedge funds and large institutions have $895K invested in Genetic Technologies Ltd. in 2020 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 2 closing their positions.
400% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 1
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
37% more capital invested
Capital invested by funds: $652K → $895K (+$243K)
17% more funds holding
Funds holding: 12 → 14 (+2)
54% less call options, than puts
Call options by funds: $257K | Put options by funds: $554K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$79.5K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$73.3K |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$68.8K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$41.6K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$17.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$83K |
| 2 |
Morgan Stanley
New York
|
-$30.2K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
-$1K |
GENE Hedge Fund Activity: Q4 2020 in Review
14 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Genetic Technologies Ltd. (GENE) for Q4 2020, worth a combined $895K — up 37% from $652K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new GENE positions and 2 closed out — a net gain of 2 holders — while 5 added to existing stakes and 1 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $79.5K. The largest seller was Virtu Financial, exiting entirely with an estimated $83K sold.
- 14 institutional investors held Genetic Technologies Ltd. (GENE) as of Q4 2020, up from 12 in Q3 2020.
- Funds reported $895K of Genetic Technologies Ltd. stock for Q4 2020, up 37% quarter-over-quarter.
- 4 funds opened new Genetic Technologies Ltd. positions in Q4 2020 and 2 closed out, a net change of +2 holders.
- The largest Genetic Technologies Ltd. buyer in Q4 2020 was Citadel Advisors, an estimated $79.5K added.
- The largest Genetic Technologies Ltd. seller in Q4 2020 was Virtu Financial, an estimated $83K sold.
Based on aggregated 13F filings for Q4 2020.